Home
Browse
Search
Statistics
About
Usage
PMID: 9261097
Loo TW, Clarke DM
Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.
J Biol Chem. 1997 Aug 22;272(34):20986-9., 1997-08-22
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
68
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:68:162
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:68:168
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:68:179
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:68:185
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:68:136
status:
NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:68:149
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:68:142
status:
NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:68:155
status:
NEW
view ABCB1 p.Met986Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:68:123
status:
NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:68:129
status:
NEW
view ABCB1 p.Ser979Cys details
To test these predictions, we introduced pairs of cysteines into a Cys-less mutant of P-glycoprotein to create the mutants
F336C
/
S979C
,
L339C
/
V982C
,
F343C
/
M986C
,
G346C
/
G989C
, and
P350C
/
S993C
.
Login to comment
76
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:76:106
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:76:112
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:76:123
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:76:130
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:76:93
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:76:99
status:
NEW
view ABCB1 p.Met986Cys details
Fig. 1D shows that a product with reduced mobility on SDS-PAGE gels was present when mutants
F343C
/
M986C
,
G346C
/
G989C
, and
P350C
/
S993C
were treated with oxidant.
Login to comment
77
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:77:54
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:77:60
status:
NEW
view ABCB1 p.Ser993Cys details
The highest level of cross-linking occurred in mutant
P350C
/
S993C
, since most of the protein migrated with reduced mobility after treatment with oxidant (Fig. 1D, lane 14).
Login to comment
78
ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:78:65
status:
NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:78:71
status:
NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:78:49
status:
NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:78:55
status:
NEW
view ABCB1 p.Ser979Cys details
No cross-linked product was observed for mutants
F336C
/
S979C
and
L339C
/
V982C
.
Login to comment
80
ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:80:36
status:
NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:80:49
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Val991Cys
X
ABCB1 p.Val991Cys 9261097:80:86
status:
NEW
view ABCB1 p.Val991Cys details
ABCB1 p.Phe335Cys
X
ABCB1 p.Phe335Cys 9261097:80:23
status:
NEW
view ABCB1 p.Phe335Cys details
ABCB1 p.Leu976Cys
X
ABCB1 p.Leu976Cys 9261097:80:29
status:
NEW
view ABCB1 p.Leu976Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:80:42
status:
NEW
view ABCB1 p.Ser979Cys details
ABCB1 p.Phe983Cys
X
ABCB1 p.Phe983Cys 9261097:80:55
status:
NEW
view ABCB1 p.Phe983Cys details
ABCB1 p.Ser351Cys
X
ABCB1 p.Ser351Cys 9261097:80:79
status:
NEW
view ABCB1 p.Ser351Cys details
ABCB1 p.Ala987Cys
X
ABCB1 p.Ala987Cys 9261097:80:68
status:
NEW
view ABCB1 p.Ala987Cys details
We also tested mutants
F335C
/
L976C
,
L339C
/
S979C
,
F343C
/
F983C
, G347C/
A987C
, and
S351C
/
V991C
for cross-linking since they were predicted to lie on opposing faces of TM6 and TM12 modeled in a right-handed coiled-coil.
Login to comment
82
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:82:144
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:82:138
status:
NEW
view ABCB1 p.Leu332Cys details
Effect of Nucleotides and Drug Substrates on Cross-linking-An interesting observation was that the amount of cross-linking seen in mutant
L332C
/
L975C
in whole cells (9) varied with the metabolic state of the transfected cells.
Login to comment
84
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:84:62
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:84:56
status:
NEW
view ABCB1 p.Leu332Cys details
A possible explanation was that cross-linking of mutant
L332C
/
L975C
was promoted by the presence of ATP.
Login to comment
91
ABCB1 p.Phe336Ser
X
ABCB1 p.Phe336Ser 9261097:91:20
status:
NEW
view ABCB1 p.Phe336Ser details
ABCB1 p.Phe343Met
X
ABCB1 p.Phe343Met 9261097:91:54
status:
NEW
view ABCB1 p.Phe343Met details
ABCB1 p.Leu339Val
X
ABCB1 p.Leu339Val 9261097:91:37
status:
NEW
view ABCB1 p.Leu339Val details
ABCB1 p.Pro350Ser
X
ABCB1 p.Pro350Ser 9261097:91:92
status:
NEW
view ABCB1 p.Pro350Ser details
The paired residues
Phe-336/Ser
-979,
Leu-339/Val
-982,
Phe-343/Met
-986, Gly-346/Gly-989, and
Pro-350/Ser
993 predicted to be close to each other (C, shaded circles) were replaced with cysteine and the mutant P-glycoproteins expressed in HEK 293 cells.
Login to comment
96
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:96:22
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:96:16
status:
NEW
view ABCB1 p.Leu332Cys details
pressing mutant
L332C
/
L975C
were cross-linked in the presence of nucleotides.
Login to comment
99
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:99:59
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:99:49
status:
NEW
view ABCB1 p.Leu332Cys details
These results suggest that cross-linking between
L332C
and
L975C
occurred during ATP hydrolysis.
Login to comment
100
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:100:83
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:100:89
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:100:100
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:100:106
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:100:70
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:100:76
status:
NEW
view ABCB1 p.Met986Cys details
The effect of nucleotides on cross-linking was also tested on mutants
F343C
/
M986C
,
G346C
/
G989C
, and
P350C
/
S993C
.
Login to comment
103
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:103:70
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:103:64
status:
NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:103:90
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:103:96
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:103:107
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:103:114
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:103:77
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:103:83
status:
NEW
view ABCB1 p.Met986Cys details
To test the effect of drug substrates, cross-linking of mutants
L332C
/
L975C
,
F343C
/
M986C
,
G346C
/
G989C
, and
P350C
/
S993C
was done in the presence of verapamil, cyclosporin A, vinblastine, or colchicine.
Login to comment
104
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:104:54
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:104:48
status:
NEW
view ABCB1 p.Leu332Cys details
No cross-linked product was observed for mutant
L332C
/
L975C
(Fig. 3A).
Login to comment
105
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:105:105
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:105:111
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:105:198
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:105:204
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:105:89
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:105:95
status:
NEW
view ABCB1 p.Met986Cys details
By contrast, all the drug substrates were effective in blocking cross-linking of mutants
F343C
/
M986C
and
G346C
/
G989C
(Fig. 3, B and C), but were less effective in preventing cross-linking of mutant
P350C
/
S993C
(Fig. 3D).
Login to comment
106
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:106:10
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:106:16
status:
NEW
view ABCB1 p.Ser993Cys details
In mutant
P350C
/
S993C
, verapamil, cyclosporin A, and vinblastine were more effective than colchicine in inhibiting cross-linking.
Login to comment
107
ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:107:23
status:
NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:107:29
status:
NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:107:14
status:
NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:107:8
status:
NEW
view ABCB1 p.Ser979Cys details
Mutants
S979C
/
F336C
or
L339C
/
V982C
did not yield any cross-linked product even in the presence of ATP or drug substrates (data not shown).
Login to comment
108
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:108:74
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:108:68
status:
NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:108:94
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:108:100
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:108:111
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:108:117
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:108:81
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:108:87
status:
NEW
view ABCB1 p.Met986Cys details
Effect of Cross-linking on Drug-stimulated ATPase Activity- Mutants
L332C
/
L975C
,
F343C
/
M986C
,
G346C
/
G989C
, and
P350C
/
S993C
were still active since they retained about 90, 30, 10, and 70%, respectively, of the verapamil-stimulated ATPase activity of the Cys-less P-glycoprotein.
Login to comment
109
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:109:82
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:109:76
status:
NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:109:38
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:109:44
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:109:55
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:109:61
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:109:25
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:109:31
status:
NEW
view ABCB1 p.Met986Cys details
Cross-linking of mutants
F343C
/
M986C
,
G346C
/
G989C
, and
P350C
/
S993C
, but not
L332C
/
L975C
, was reversed by treatment with dithiothreitol (Fig. 4A).
Login to comment
111
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:111:7
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:111:13
status:
NEW
view ABCB1 p.Ser993Cys details
Mutant
P350C
/
S993C
was tested because it exhibited the greatest degree of cross-linking (Fig. 1D).
Login to comment
112
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:112:20
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:112:26
status:
NEW
view ABCB1 p.Ser993Cys details
In addition, mutant
P350C
/
S993C
had the highest activity of those mutants whose cross-linked products were sensitive to dithiothreitol.
Login to comment
113
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:113:68
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:113:74
status:
NEW
view ABCB1 p.Ser993Cys details
Membranes prepared from HEK 293 cells expressing Cys-less or mutant
P350C
/
S993C
P-glycoprotein- (His)10 were treated with or without 2 mM copper phenanthroline for 10 min at 37 °C.
Login to comment
116
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:116:52
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:116:58
status:
NEW
view ABCB1 p.Ser993Cys details
Fig. 4B (lane 4) shows that the cross-linked mutant
P350C
/
S993C
was also efficiently recovered, indicating that the histidine tag remained accessible after cross-linking.
Login to comment
119
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:119:7
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:119:13
status:
NEW
view ABCB1 p.Ser993Cys details
Mutant
P350C
/
S993C
, however, showed approximately 75% reduction of the verapamil-stimulated ATPase activity after cross-linking.
Login to comment
121
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:121:84
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:121:94
status:
NEW
view ABCB1 p.Ser993Cys details
This result suggested that dithiothreitol broke the disulfide bond between residues
P350C
and
S993C
and allowed movement to occur between TM6 and TM12 during drug-stimulated ATPase activity.
Login to comment
124
ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:124:54
status:
NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:124:60
status:
NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:124:39
status:
NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:124:45
status:
NEW
view ABCB1 p.Ser979Cys details
Cross-linking was not observed between
F336C
/
S979C
or
L339C
/
V982C
, even in the presence of ATP or drug substrates FIG. 2.
Login to comment
126
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:126:63
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:126:57
status:
NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:126:91
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:126:97
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:126:117
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:126:74
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:126:80
status:
NEW
view ABCB1 p.Met986Cys details
Membranes prepared from HEK 293 cells expressing mutants
L332C
/
L975C
(A),
F343C
/
M986C
(B),
G346C
/
G989C
(C), and P350/
S993C
(D) were treated without (-) or with (ϩ) 2 mM (A) or 0.2 mM (B-D) copper phenanthroline for 10 min at 37 °C in the presence of 5 mM ATP, 5 mM ATP plus 0.2 mM sodium vanadate, 5 mM ADP, 5 mM ADP plus 0.2 mM sodium vanadate, or 5 mM AMP-PNP.
Login to comment
132
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:132:64
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:132:57
status:
NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:132:92
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:132:98
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:132:118
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:132:75
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:132:81
status:
NEW
view ABCB1 p.Met986Cys details
Membranes prepared from HEK 293 cells expressing mutants
L332C
/
L975C
(A),
F343C
/
M986C
(B),
G346C
/
G989C
(C), and P350/
S993C
(D) were treated without (-) or with (ϩ) 2 mM (A) or 0.2 mM (B-D) copper phenanthroline for 10 min at 37 °C in the presence of 1 mM verapamil, 0.1 mM vinblastine, 50 M cyclosporin A, or 5 mM colchicine.
Login to comment
140
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:140:95
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:140:88
status:
NEW
view ABCB1 p.Leu332Cys details
ATP hydrolysis rather than nucleotide binding was responsible for cross-linking between
L332C
/
L975C
.
Login to comment
142
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:142:73
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:142:130
status:
NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:142:67
status:
NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:142:124
status:
NEW
view ABCB1 p.Leu332Cys details
The observation that ATP hydrolysis promoted cross-linking between
L332C
/
L975C
suggests that inhibition of cross-linking of
L332C
/
L975C
in whole cells by verapamil or vinblastine occurred indirectly through depletion of intracellular ATP.
Login to comment
144
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:144:65
status:
NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:144:71
status:
NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:144:82
status:
NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:144:88
status:
NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:144:51
status:
NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:144:58
status:
NEW
view ABCB1 p.Met986Cys details
Drug substrates inhibited cross-linking of mutants
F343C
/
M986C
,
G346C
/
G989C
, and
P350C
/
S993C
.
Login to comment